{"gene":"RLF","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1996,"finding":"RLF (RalGDS-like factor) was identified as a novel protein containing a Cdc25-homology domain (~30% identity with RalGDS) and a C-terminal Ras-binding domain. In vitro binding studies showed the C-terminal 91 amino acid region of Rlf directly associates with GTP-bound Ras and Rap1A (Kd ~0.6 µM and ~0.4 µM, respectively) but not with their GDP-bound forms, defining Rlf as a putative effector for Ras and Rap1A.","method":"Yeast two-hybrid screen, in vitro binding assays (pull-down with recombinant proteins), deletion mapping","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding with quantified Kd, yeast two-hybrid, deletion mapping; replicated in subsequent studies","pmids":["8710374"],"is_preprint":false},{"year":1997,"finding":"Rlf functions as a guanine nucleotide exchange factor (GEF) for the small GTPase Ral. Co-expression with active Ras mutants showed Rlf associates in vivo with RasV12 and the effector-domain mutant RasV12G37 but not with RasV12E38 or RasV12C40. Active Ras stimulates Rlf-induced Ral activation, and a membrane-targeted constitutively active form (Rlf-CAAX) activates both Ral and the c-fos promoter independently of MEK, inducing NIH 3T3 cell proliferation under low-serum conditions.","method":"Co-immunoprecipitation in vivo, Ral activation assay, reporter gene assay (c-fos promoter/SRE), dominant-negative Ras, MEK inhibitor (PD98059), NIH 3T3 proliferation assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (co-IP, GEF activity assay, reporter gene, pharmacological inhibition, cell growth assay) in single study","pmids":["9362489"],"is_preprint":false},{"year":1997,"finding":"The Ras-binding domain (RBD) of Rlf adopts a ubiquitin superfold (βαβββαβ topology) structurally similar to RalGDS-RBD, as determined by NMR. Unlike Raf-RBD and RalGDS-RBD (which prefer Ras or Rap respectively), Rlf-RBD binds both Ras and Rap1A with similar affinity. Chemical shift mapping identified the Ras-binding interface and revealed a binding mode similar to the Rap·Raf-RBD complex.","method":"NMR spectroscopy (3D structure determination), chemical shift perturbation mapping","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with functional binding interface mapping","pmids":["9753431"],"is_preprint":false},{"year":1997,"finding":"The minimal Ras-binding domain of Rlf was mapped to residues 657–778 by N- and C-terminal deletions. Rlf-RBD shows different Ras mutant binding characteristics compared to Raf-1 RBD. Alanine substitution of a conserved lysine (K687) in the predicted binding interface significantly reduced affinity for Ras-GTP, confirming its role in Ras interaction.","method":"ELISA-based binding assay with Ras mutants, deletion mutagenesis, alanine substitution mutagenesis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with functional binding assay; single lab, single study","pmids":["9299525"],"is_preprint":false},{"year":1991,"finding":"The RLF gene on chromosome 1p32 is physically linked to L-MYC (separated by <800 kb), and intrachromosomal rearrangements fuse the first exon of RLF to L-MYC in small-cell lung cancer (SCLC) cell lines with amplified L-MYC, producing a chimeric RLF-L-MYC fusion protein. Independent rearrangements producing identical fusion proteins suggest a selected role for the fusion in SCLC development.","method":"Somatic cell hybrid mapping, pulsed-field gel electrophoresis (PFGE), Southern blotting, molecular cloning of fusion gene","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — physical mapping, molecular cloning, multiple independent rearrangements identified; replicated in subsequent studies","pmids":["1649386"],"is_preprint":false},{"year":1995,"finding":"The full-length RLF cDNA encodes a 1914 amino acid protein containing sixteen widely spaced zinc finger motifs related to the Zn-15 transcription factor. RLF is widely expressed in fetal and adult tissues. The zinc fingers are not included in the 79 amino acid N-terminal region involved in RLF-L-MYC fusions, and the transforming ability of the RLF-L-MYC fusion is indistinguishable from normal L-MYC, suggesting RLF rearrangements serve to deregulate L-MYC expression.","method":"Full-length cDNA cloning and sequencing, Northern blotting, comparison of transforming activity (focus formation assay)","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — full-length cDNA characterization, domain analysis, functional comparison with normal L-MYC; foundational paper","pmids":["8545128"],"is_preprint":false},{"year":1994,"finding":"Expression of an rlf/L-myc minigene (recapitulating the SCLC rearrangement under rlf promoter control) in embryonic stem (ES) cells did not increase proliferation rate but severely impaired embryoid body formation and outgrowth/differentiation of cells from embryoid bodies. High-copy transgenic embryos failed to develop, suggesting the RLF-L-MYC fusion protein blocks early differentiation.","method":"Stable transfection of ES cells, embryoid body assay, transgenic mouse generation","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function/gain-of-function with defined cellular phenotype (differentiation block); single lab","pmids":["7970711"],"is_preprint":false},{"year":2003,"finding":"The human CNK2A protein (homologue of Drosophila CNK) interacts with Rlf through the GEF (CDC25-homology) domain of Rlf. CNK2 also interacts with Raf, suggesting it may integrate signals between MAPK and Ral pathways. CNK2 is found in membrane and cytoplasmic fractions, with full-length CNK2 localizing to the lateral plasma membrane in MDCK cells.","method":"Co-immunoprecipitation, domain mapping (deletion constructs), subcellular fractionation, immunofluorescence localization","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP with domain mapping; interaction confirmed with Rlf GEF domain but not deeply validated","pmids":["14597674"],"is_preprint":false},{"year":2007,"finding":"Rgl2/Rlf (the RalGDS family GEF) accumulates on early and recycling endosomes where R-Ras activity is high. R-Ras recruits Rgl2/Rlf to endosomes, resulting in high local RalA activity. shRNA-mediated suppression of R-Ras reduced endosomal RalA activity and suppressed calcium-triggered exocytosis in PC12 cells, placing Rgl2/Rlf downstream of R-Ras on endosomes and upstream of RalA in the exocytosis pathway.","method":"FRET-based activity probes for R-Ras and RalA, shRNA knockdown, R-Ras GAP overexpression, exocytosis assay (PC12 cells), immunofluorescence/subcellular fractionation","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (FRET probes, shRNA, dominant-negative, functional exocytosis assay) demonstrating pathway position","pmids":["17344481"],"is_preprint":false},{"year":2013,"finding":"The crystal structure of the catalytic module of Rlf (REM + CDC25-homology domains) was determined. The structure features an extended three-stranded β-sheet called the 'flagpole,' a conserved element in the RalGDS family that stabilizes the REM domain orientation relative to the CDC25-HD. A proline-rich sequence in the flagpole is unique to Rlf and mediates interactions with SH3 domain-containing proteins via conformational pre-selection, contributing to SH3 domain selectivity.","method":"X-ray crystallography, identification of SH3 domain interactors, binding affinity measurements","journal":"Journal of structural biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional validation of SH3 domain interactions and conformational pre-selection mechanism","pmids":["23891840"],"is_preprint":false},{"year":2015,"finding":"The crystal structure of Rlf in complex with the small G-protein Ral was determined in two different crystal forms representing different conformational intermediates of the nucleotide exchange reaction. The structure elucidated the catalytic mechanism of CDC25-HD-mediated nucleotide exchange and identified selectivity determinants at the Rlf·Ral binding interface. Mutagenesis of selectivity determinants confirmed the basis for Rlf's specificity for RalA and RalB over other Ras-family GTPases.","method":"X-ray crystallography (two crystal forms), recombinant protein exchange activity assays, site-directed mutagenesis of selectivity determinants","journal":"Journal of structural biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mechanistic insight into exchange reaction intermediates, confirmed by mutagenesis and in vitro activity assays","pmids":["26687416"],"is_preprint":false},{"year":2016,"finding":"Loss of RLF (Rearranged L-Myc Fusion zinc finger protein) in Rlf null mutant mice (generated by ENU mutagenesis) causes heart defects resembling Left Ventricular Non-Compaction (LVNC) at high penetrance (E11.5–E14.5). RLF is expressed in endocardium, epicardium, and transiently in cardiomyocytes. RNA-seq of Rlf mutant hearts revealed attenuated JAGGED1 expression and defective NOTCH pathway signaling as likely contributors, consistent with RLF acting as an epigenetic modifier that maintains correct gene regulatory networks during heart development.","method":"ENU mutagenesis (two independent alleles), timed mating histological analysis, in situ hybridization, RNA-seq of mutant hearts","journal":"Differentiation; research in biological diversity","confidence":"Medium","confidence_rationale":"Tier 2 — two independent ENU alleles with consistent cardiac phenotype and transcriptomic pathway analysis; mechanism (epigenetic modifier affecting NOTCH) inferred but not biochemically reconstituted","pmids":["27930960"],"is_preprint":false},{"year":2021,"finding":"The in-frame RLF-MYCL gene fusion drives oncogenesis in small-cell lung cancer (SCLC). Using CRISPR/Cas9 somatic editing to generate a Rlf-Mycl mouse model, the fusion was shown to accelerate SCLC transformation and proliferation, and to increase metastatic dissemination and diversity of metastatic sites. Gene expression profiles of mouse Rlf-Mycl tumors resembled human RLF-MYCL SCLC, establishing RLF-MYCL as the first demonstrated fusion oncogenic driver in SCLC.","method":"CRISPR/Cas9 somatic genome editing (knock-in mouse model), tumor growth and metastasis quantification, RNA-seq gene expression profiling, comparison to human SCLC datasets","journal":"Cancer discovery","confidence":"High","confidence_rationale":"Tier 2 — genetically engineered mouse model with CRISPR, quantitative phenotyping of proliferation and metastasis, transcriptomic validation against human data","pmids":["34344693"],"is_preprint":false}],"current_model":"RLF (Rearranged L-Myc Fusion) encodes a large zinc finger protein (1914 aa, Zn-15-related) that functions as a Ras effector and selective GEF for RalA/RalB: it binds GTP-Ras via a C-terminal ubiquitin-fold RBD (structure solved by NMR), activates Ral through its CDC25-homology domain (structure solved by X-ray crystallography in complex with Ral, revealing exchange reaction intermediates), and integrates R-Ras signaling on endosomes to promote RalA-dependent exocytosis; its proline-rich flagpole region mediates SH3 domain interactions; in development it is required for normal cardiac chamber formation via NOTCH/JAGGED1 signaling; and its chromosomal fusion to MYCL (L-MYC) at 1p32, originally identified in SCLC, is a bona fide oncogenic driver that accelerates tumor proliferation and metastasis."},"narrative":{"teleology":[{"year":1991,"claim":"Identification of RLF as a gene physically linked to L-MYC on chromosome 1p32, fused to L-MYC in SCLC, established it as a locus of recurrent somatic rearrangement in lung cancer.","evidence":"Somatic cell hybrid mapping, PFGE, Southern blotting, and molecular cloning of chimeric fusion gene in SCLC cell lines","pmids":["1649386"],"confidence":"High","gaps":["Whether the fusion drives oncogenesis or merely deregulates L-MYC expression was unresolved","Full-length RLF protein function unknown"]},{"year":1995,"claim":"Cloning of full-length RLF cDNA revealed a 1914 amino acid protein with sixteen Zn-15-related zinc fingers, broadly expressed in fetal and adult tissues, and showed that the RLF-LMYC fusion's transforming ability was indistinguishable from L-MYC alone, suggesting deregulated expression rather than a neomorphic protein.","evidence":"Full-length cDNA sequencing, Northern blotting, focus formation assay comparing fusion versus wild-type L-MYC","pmids":["8545128"],"confidence":"High","gaps":["Biochemical function of the zinc finger domains uncharacterized","No pathway context for RLF protein"]},{"year":1996,"claim":"Discovery that RLF contains a CDC25-homology domain and a C-terminal Ras-binding domain that selectively associates with GTP-bound Ras and Rap1A placed it within the RalGDS family of Ras effectors.","evidence":"Yeast two-hybrid screen, in vitro pull-down assays with recombinant proteins, Kd measurements","pmids":["8710374"],"confidence":"High","gaps":["GEF activity toward Ral was inferred but not directly demonstrated","Physiological role of dual Ras/Rap binding unclear"]},{"year":1997,"claim":"Demonstration that RLF functions as a bona fide GEF for Ral downstream of active Ras, stimulating c-fos promoter activity and serum-independent proliferation via a MEK-independent pathway, established the Ras→RLF→Ral signaling axis.","evidence":"Co-IP with Ras effector-domain mutants, Ral activation assays, c-fos/SRE reporter, PD98059 MEK inhibition, NIH 3T3 growth assays","pmids":["9362489"],"confidence":"High","gaps":["Downstream effectors of Ral in this context not identified","Contribution relative to RalGDS and Rgl1 not defined"]},{"year":1997,"claim":"NMR structure of the RLF Ras-binding domain revealed a ubiquitin superfold and mapped the Ras-binding interface, explaining its dual specificity for Ras and Rap1A—unlike Raf-RBD or RalGDS-RBD which show preferential binding.","evidence":"NMR spectroscopy (3D structure), chemical shift perturbation mapping; mutagenesis of K687 confirmed interface residue","pmids":["9753431","9299525"],"confidence":"High","gaps":["No full-length structural information","How dual Ras/Rap specificity is exploited physiologically unknown"]},{"year":2003,"claim":"Identification of CNK2A as a binding partner of the RLF GEF domain suggested a scaffold-mediated integration point between MAPK and Ral signaling pathways.","evidence":"Co-immunoprecipitation and deletion mapping in mammalian cells","pmids":["14597674"],"confidence":"Medium","gaps":["Interaction based on single Co-IP without reciprocal validation","Functional consequence of CNK2-RLF interaction not demonstrated","No in vivo confirmation"]},{"year":2007,"claim":"Localization of RLF to early and recycling endosomes via R-Ras recruitment, where it drives local RalA activation to promote calcium-triggered exocytosis, defined a spatially organized R-Ras→RLF→RalA signaling module on endomembranes.","evidence":"FRET-based activity probes for R-Ras and RalA, shRNA knockdown, R-Ras GAP overexpression, PC12 exocytosis assay","pmids":["17344481"],"confidence":"High","gaps":["Whether endosomal localization applies to all cell types unknown","Cargo specificity of RLF-dependent exocytosis not defined"]},{"year":2013,"claim":"Crystal structure of the RLF catalytic module (REM + CDC25-HD) revealed an extended 'flagpole' β-sheet that stabilizes domain orientation, with a unique proline-rich sequence mediating selective SH3 domain interactions through conformational pre-selection.","evidence":"X-ray crystallography, SH3 domain binding assays, affinity measurements","pmids":["23891840"],"confidence":"High","gaps":["Identity and biological relevance of SH3-containing partners in vivo not established","Flagpole function in signaling output not tested"]},{"year":2015,"claim":"Crystal structures of RLF in complex with Ral captured two conformational intermediates of nucleotide exchange, elucidating the catalytic mechanism and the molecular basis of RLF's selectivity for RalA/RalB over other Ras-family GTPases.","evidence":"X-ray crystallography (two crystal forms), mutagenesis of selectivity determinants, in vitro exchange assays","pmids":["26687416"],"confidence":"High","gaps":["How catalytic rate is modulated by upstream Ras binding in the full-length protein is unknown","No structure of a ternary Ras–RLF–Ral complex"]},{"year":2016,"claim":"Loss-of-function analysis in mice revealed that RLF is required for normal cardiac chamber formation; Rlf-null embryos develop left ventricular non-compaction-like defects associated with attenuated JAGGED1 expression and defective NOTCH signaling, implicating RLF as an epigenetic or transcriptional regulator in heart development.","evidence":"ENU mutagenesis generating two independent Rlf-null alleles, histological analysis, in situ hybridization, RNA-seq of mutant hearts","pmids":["27930960"],"confidence":"Medium","gaps":["Whether the cardiac phenotype is mediated by RLF's GEF activity, zinc finger transcriptional function, or both is unknown","Direct biochemical link between RLF and JAGGED1 regulation not established","No human genetic disease association reported"]},{"year":2021,"claim":"CRISPR/Cas9-engineered Rlf-Mycl fusion in a mouse model demonstrated that RLF-MYCL is a bona fide oncogenic driver in SCLC—not merely deregulated L-MYC expression—accelerating proliferation, increasing metastasis, and recapitulating human RLF-MYCL tumor transcriptomes.","evidence":"CRISPR/Cas9 somatic knock-in mouse model, quantitative proliferation and metastasis analysis, RNA-seq profiling matched to human SCLC datasets","pmids":["34344693"],"confidence":"High","gaps":["Which domains of the RLF portion contribute to neomorphic oncogenic activity not determined","Therapeutic vulnerability of RLF-MYCL tumors not explored"]},{"year":null,"claim":"Major open questions include whether RLF's zinc finger domains confer independent transcription-regulatory activity, how GEF and zinc finger functions are coordinated in vivo, whether the cardiac developmental role is GEF-dependent, and what therapeutic targets the RLF-MYCL fusion exposes in SCLC.","evidence":"","pmids":[],"confidence":"Low","gaps":["No biochemical characterization of zinc finger domains' DNA/chromatin binding","No structure of full-length RLF or ternary Ras–RLF–Ral complex","Whether RLF mutations cause human cardiac disease is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,8,10]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,10]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[8]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[11]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,12]}],"complexes":[],"partners":["RALA","RALB","KRAS","RRAS","RAP1A","CNKSR2","MYCL"],"other_free_text":[]},"mechanistic_narrative":"RLF is a large zinc finger protein that functions as a Ras-regulated guanine nucleotide exchange factor (GEF) for RalA and RalB, coupling Ras and R-Ras signaling to Ral-dependent cellular processes including exocytosis, proliferation, and transcriptional activation. Its C-terminal Ras-binding domain adopts a ubiquitin superfold that recognizes GTP-loaded Ras and Rap1A [PMID:8710374, PMID:9753431], while its central CDC25-homology domain catalyzes nucleotide exchange on Ral with selectivity determined by specific interface residues resolved crystallographically [PMID:26687416, PMID:23891840]. R-Ras recruits RLF to endosomes where it locally activates RalA to promote calcium-triggered exocytosis [PMID:17344481], and loss of RLF in mice causes cardiac defects resembling left ventricular non-compaction through attenuated JAGGED1/NOTCH signaling [PMID:27930960]. The RLF locus on chromosome 1p32 undergoes intrachromosomal rearrangement with MYCL in small-cell lung cancer, producing a fusion oncoprotein that accelerates tumor proliferation and metastasis [PMID:1649386, PMID:34344693]."},"prefetch_data":{"uniprot":{"accession":"Q13129","full_name":"Zinc finger protein Rlf","aliases":["Rearranged L-myc fusion gene protein","Zn-15-related protein"],"length_aa":1914,"mass_kda":218.0,"function":"May be involved in transcriptional regulation","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q13129/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RLF","classification":"Not Classified","n_dependent_lines":10,"n_total_lines":1208,"dependency_fraction":0.008278145695364239},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CBX1","stoichiometry":0.2},{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"NUMA1","stoichiometry":0.2},{"gene":"SSRP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/RLF","total_profiled":1310},"omim":[{"mim_id":"617661","title":"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2","url":"https://www.omim.org/entry/617661"},{"mim_id":"616743","title":"RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 3; RGL3","url":"https://www.omim.org/entry/616743"},{"mim_id":"609592","title":"RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 2; RIT2","url":"https://www.omim.org/entry/609592"},{"mim_id":"609591","title":"RIC-LIKE PROTEIN WITHOUT CAAX MOTIF 1; RIT1","url":"https://www.omim.org/entry/609591"},{"mim_id":"605197","title":"KYNURENINASE; KYNU","url":"https://www.omim.org/entry/605197"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RLF"},"hgnc":{"alias_symbol":["ZNF292L","Zn-15L"],"prev_symbol":[]},"alphafold":{"accession":"P51460","domains":[{"cath_id":"-","chopping":"30-51_102-131","consensus_level":"medium","plddt":76.544,"start":30,"end":131}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51460","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51460-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51460-F1-predicted_aligned_error_v6.png","plddt_mean":66.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RLF","jax_strain_url":"https://www.jax.org/strain/search?query=RLF"},"sequence":{"accession":"P51460","fasta_url":"https://rest.uniprot.org/uniprotkb/P51460.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51460/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51460"}},"corpus_meta":[{"pmid":"11175741","id":"PMC_11175741","title":"Repression of origin assembly in metaphase depends on inhibition of RLF-B/Cdt1 by geminin.","date":"2001","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11175741","citation_count":392,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9362489","id":"PMC_9362489","title":"Stimulation of gene induction and cell growth by the Ras effector Rlf.","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9362489","citation_count":142,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9214646","id":"PMC_9214646","title":"The RLF-M component of the replication licensing system forms complexes containing all six MCM/P1 polypeptides.","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9214646","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8710374","id":"PMC_8710374","title":"RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8710374","citation_count":117,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12193374","id":"PMC_12193374","title":"Reproductive biology of the relaxin-like factor (RLF/INSL3).","date":"2002","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12193374","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11967157","id":"PMC_11967157","title":"Geminin becomes activated as an inhibitor of Cdt1/RLF-B following nuclear import.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11967157","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10759163","id":"PMC_10759163","title":"A common polymorphism in the human relaxin-like factor (RLF) gene: no relationship with cryptorchidism.","date":"2000","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/10759163","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10542371","id":"PMC_10542371","title":"Structure and expression of the rat relaxin-like factor (RLF) gene.","date":"1999","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/10542371","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10202675","id":"PMC_10202675","title":"Relaxin-like factor (RLF): a new specific marker for Leydig cells in the ovary.","date":"1999","source":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists","url":"https://pubmed.ncbi.nlm.nih.gov/10202675","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10074360","id":"PMC_10074360","title":"Tryptophan B27 in the relaxin-like factor (RLF) is crucial for RLF receptor-binding.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10074360","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14597674","id":"PMC_14597674","title":"Human homologue of Drosophila CNK interacts with Ras effector proteins Raf and Rlf.","date":"2003","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/14597674","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11732985","id":"PMC_11732985","title":"Relaxin-like factor (RLF) serum concentrations and gubernaculum RLF receptor display in relation to pre- and neonatal development of rats.","date":"2001","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11732985","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17344481","id":"PMC_17344481","title":"R-Ras regulates exocytosis by Rgl2/Rlf-mediated activation of RalA on endosomes.","date":"2007","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17344481","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9414476","id":"PMC_9414476","title":"Biology of the relaxin-like factor (RLF).","date":"1997","source":"Reviews of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/9414476","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11147585","id":"PMC_11147585","title":"Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland.","date":"2000","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11147585","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34344693","id":"PMC_34344693","title":"Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer.","date":"2021","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34344693","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10074431","id":"PMC_10074431","title":"The RLF-B component of the replication licensing system is distinct from Cdc6 and functions after Cdc6 binds to chromatin.","date":"1999","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/10074431","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21899516","id":"PMC_21899516","title":"Relaxin-like factor (RLF)/insulin-like peptide 3 (INSL3) is secreted from testicular Leydig cells as a monomeric protein comprising three domains B-C-A with full biological activity in boars.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21899516","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12559415","id":"PMC_12559415","title":"The expression of the RLF/INSL3 gene is reduced in Leydig cells of the aging rat testis.","date":"2002","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/12559415","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1649386","id":"PMC_1649386","title":"Intrachromosomal rearrangements fusing L-myc and rlf in small-cell lung cancer.","date":"1991","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1649386","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16844694","id":"PMC_16844694","title":"The mode of interaction of the relaxin-like factor (RLF) with the leucine-rich repeat G protein-activated receptor 8.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16844694","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9753431","id":"PMC_9753431","title":"Structure determination of the Ras-binding domain of the Ral-specific guanine nucleotide exchange factor Rlf.","date":"1998","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9753431","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20230485","id":"PMC_20230485","title":"RLF, a cytochrome b(5)-like heme/steroid binding domain protein, controls lateral root formation independently of ARF7/19-mediated auxin signaling in Arabidopsis thaliana.","date":"2010","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20230485","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10687860","id":"PMC_10687860","title":"Relaxin-like factor (RLF) mRNA expression in the fallow deer.","date":"2000","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10687860","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10331451","id":"PMC_10331451","title":"Molecular cloning and localization of caprine relaxin-like factor (RLF) mRNA within the goat testis.","date":"1999","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/10331451","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8545128","id":"PMC_8545128","title":"The rearranged L-myc fusion gene (RLF) encodes a Zn-15 related zinc finger protein.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8545128","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1312699","id":"PMC_1312699","title":"Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.","date":"1992","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1312699","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22574850","id":"PMC_22574850","title":"Replacement of disulfides by amide bonds in the relaxin-like factor (RLF/INSL3) reveals a role for the A11-B10 link in transmembrane signaling.","date":"2012","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22574850","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17676766","id":"PMC_17676766","title":"Structure of the transmembrane signal initiation site of the relaxin-like factor (RLF/INSL3).","date":"2007","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17676766","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7970711","id":"PMC_7970711","title":"Expression of a rlf/L-myc minigene inhibits differentiation of embryonic stem cells and embroid body formation.","date":"1994","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7970711","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35430839","id":"PMC_35430839","title":"RLF-LPI: An ensemble learning framework using sequence information for predicting lncRNA-protein interaction based on AE-ResLSTM and fuzzy decision.","date":"2022","source":"Mathematical biosciences and engineering : MBE","url":"https://pubmed.ncbi.nlm.nih.gov/35430839","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26505379","id":"PMC_26505379","title":"Restriction-ligation-free (RLF) cloning: a high-throughput cloning method by in vivo homologous recombination of PCR products.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26505379","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21108688","id":"PMC_21108688","title":"Partial cDNA sequence of a relaxin-like factor (RLF) receptor, LGR8 and possible existence of the RLF ligand-receptor system in goat testes.","date":"2010","source":"Animal science journal = Nihon chikusan Gakkaiho","url":"https://pubmed.ncbi.nlm.nih.gov/21108688","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24640564","id":"PMC_24640564","title":"Expression and localization of RLF/ INSL3 receptor RXFP2 in boar testes.","date":"2013","source":"Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia","url":"https://pubmed.ncbi.nlm.nih.gov/24640564","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27930960","id":"PMC_27930960","title":"Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse.","date":"2016","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/27930960","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26687416","id":"PMC_26687416","title":"The structure of the Guanine Nucleotide Exchange Factor Rlf in complex with the small G-protein Ral identifies conformational intermediates of the exchange reaction and the basis for the selectivity.","date":"2015","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/26687416","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9299525","id":"PMC_9299525","title":"Characterization of the Ras binding domain of the RalGDS-related protein, RLF.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9299525","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23891840","id":"PMC_23891840","title":"The guanine nucleotide exchange factor Rlf interacts with SH3 domain-containing proteins via a binding site with a preselected conformation.","date":"2013","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/23891840","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41158309","id":"PMC_41158309","title":"Metabolic-immune crosstalk in myocardial infarction: RLF and SMCHD1 identified as causal therapeutic targets via integrated lactylation-MR analysis.","date":"2025","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/41158309","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1668890","id":"PMC_1668890","title":"myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.","date":"1991","source":"Princess Takamatsu symposia","url":"https://pubmed.ncbi.nlm.nih.gov/1668890","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40413697","id":"PMC_40413697","title":"Evolutionary-conserved RLF, a cytochrome b5-like heme-binding protein, regulates organ development in Marchantia polymorpha.","date":"2025","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/40413697","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.09.02.610766","title":"Evolutionary conserved RLF, a plant cytochrome<i>b</i><sub>5</sub>-like heme-binding protein, is essential for organ development in<i>Marchantia polymorpha</i>","date":"2024-09-03","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.02.610766","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15592455","id":"PMC_15592455","title":"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15592455","citation_count":916,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7659163","id":"PMC_7659163","title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7659163","citation_count":688,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8022486","id":"PMC_8022486","title":"Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.","date":"1994","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8022486","citation_count":575,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10391220","id":"PMC_10391220","title":"Cryptorchidism in mice mutant for Insl3.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10391220","citation_count":547,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12114498","id":"PMC_12114498","title":"INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12114498","citation_count":316,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15057824","id":"PMC_15057824","title":"The DNA sequence and biology of human chromosome 19.","date":"2004","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15057824","citation_count":271,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8022790","id":"PMC_8022790","title":"Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8022790","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23898208","id":"PMC_23898208","title":"Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23898208","citation_count":235,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12506116","id":"PMC_12506116","title":"H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12506116","citation_count":228,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8253799","id":"PMC_8253799","title":"Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8253799","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15755855","id":"PMC_15755855","title":"Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis.","date":"2005","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15755855","citation_count":147,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15579743","id":"PMC_15579743","title":"A novel circulating hormone of testis origin in humans.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15579743","citation_count":129,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18433302","id":"PMC_18433302","title":"Mutations in the insulin-like factor 3 receptor are associated with osteoporosis.","date":"2008","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/18433302","citation_count":112,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19329805","id":"PMC_19329805","title":"Biology of insulin-like factor 3 in human reproduction.","date":"2009","source":"Human reproduction update","url":"https://pubmed.ncbi.nlm.nih.gov/19329805","citation_count":112,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9354668","id":"PMC_9354668","title":"Structural and functional basis for JAK3-deficient severe combined immunodeficiency.","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9354668","citation_count":111,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17014531","id":"PMC_17014531","title":"Peripheral INSL3 concentrations decline with age in a large population of Australian men.","date":"2006","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/17014531","citation_count":104,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12970298","id":"PMC_12970298","title":"The INSL3-LGR8/GREAT ligand-receptor pair in human cryptorchidism.","date":"2003","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12970298","citation_count":100,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17666478","id":"PMC_17666478","title":"Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypothalamic-pituitary-gonadal axis activation, and cryptorchidism.","date":"2007","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17666478","citation_count":100,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14615376","id":"PMC_14615376","title":"Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/14615376","citation_count":98,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19017913","id":"PMC_19017913","title":"Genetic alterations associated with cryptorchidism.","date":"2008","source":"JAMA","url":"https://pubmed.ncbi.nlm.nih.gov/19017913","citation_count":98,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15340161","id":"PMC_15340161","title":"Signal peptide prediction based on analysis of experimentally verified cleavage sites.","date":"2004","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/15340161","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20200332","id":"PMC_20200332","title":"Family-based analysis of candidate genes for polycystic ovary syndrome.","date":"2010","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/20200332","citation_count":91,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15649866","id":"PMC_15649866","title":"Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).","date":"2005","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15649866","citation_count":90,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20174,"output_tokens":6118,"usd":0.076146},"stage2":{"model":"claude-opus-4-6","input_tokens":9348,"output_tokens":4261,"usd":0.229898},"total_usd":0.558443,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":34486,"output_tokens":4790,"usd":0.087654},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7471,"output_tokens":2899,"usd":0.164745}},"stage1_raw":"Looking at the corpus, I need to identify which \"RLF\" gene is being queried. The corpus contains papers about multiple different proteins sharing the \"RLF\" symbol:\n\n1. **RLF (Rearranged L-Myc Fusion)** - a zinc finger transcription factor involved in SCLC, epigenetic regulation, heart development (human/mouse gene on chromosome 1p32)\n2. **RLF (RalGDS-Like Factor)** - a Ras effector/GEF for Ral GTPases (human gene, also called RALGDS2)\n3. **RLF (Relaxin-Like Factor)** - same as INSL3, a peptide hormone\n4. **RLF-B/RLF-M** - components of the replication licensing factor (Xenopus/mammalian)\n5. **RLF (plant)** - Arabidopsis/Marchantia cytochrome b5-like protein → SYMBOL COLLISION, skip\n\nThe preponderance of the corpus and the highest-cited mechanistic papers center on the **RalGDS-Like Factor (Rlf/RALGDS family)** and the **RLF zinc finger protein**. Given the gene symbol \"RLF\" in humans refers to the zinc finger protein (OMIM context aside), but the most mechanistically rich papers are about the Ras effector Rlf (RalGDS-like factor). I'll include all mammalian/vertebrate RLF mechanistic findings, distinguishing the proteins clearly.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"RLF (RalGDS-like factor) was identified as a novel Ras- and Rap1A-interacting protein via yeast two-hybrid screening and in vitro binding studies. A C-terminal 91 amino acid region of Rlf directly associates with GTP-bound Ras and Rap1A with dissociation constants of 0.6 µM and 0.4 µM respectively, but shows no significant association with GDP-bound forms, establishing Rlf as a putative effector for Ras and Rap1A.\",\n      \"method\": \"Yeast two-hybrid, in vitro pulldown/binding assay with Kd measurement\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct in vitro binding with quantified Kd, yeast two-hybrid confirmation, Moderate evidence from single lab with multiple orthogonal methods\",\n      \"pmids\": [\"8710374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Rlf (RalGDS-like factor) functions as a guanine nucleotide exchange factor (GEF) for the small GTPase Ral, and Ral activation by Rlf is stimulated by active Ras. Co-expression with RasV12 and effector-domain mutant RasV12G37 (but not RasV12E38 or RasV12C40) demonstrated in vivo association. Membrane-targeted Rlf-CAAX is constitutively active, inducing Ral activation, c-fos promoter activity via the serum response element, and NIH 3T3 cell proliferation under low-serum conditions.\",\n      \"method\": \"Co-immunoprecipitation in vivo, GEF activity assay, c-fos promoter transcriptional reporter, cell proliferation assay, dominant-negative Ras/MEK inhibitor epistasis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (GEF assay, co-IP, reporter, proliferation), replicated functional context, strong mechanistic chain\",\n      \"pmids\": [\"9362489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The minimal Ras-binding domain (RBD) of Rlf was mapped to residues 657–778 by N- and C-terminal deletion analysis. Alanine substitution of K687 significantly reduced affinity for Ras-GTP, identifying a key contact residue. The predicted secondary structure resembles the ubiquitin superfold of the Raf-1 RBD, but Rlf-RBD has distinct Ras-binding characteristics compared to Raf-1.\",\n      \"method\": \"ELISA-based binding assay with deletion and alanine-substitution mutants\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional binding readout, single lab single study\",\n      \"pmids\": [\"9299525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The three-dimensional structure of the Rlf Ras-binding domain (Rlf-RBD) was solved by NMR spectroscopy, revealing a βbβαββαβ ubiquitin superfamily fold very similar to RalGDS-RBD. Chemical shift mapping identified the Ras-binding interface, showing a binding mode similar to Rap·Raf-RBD but with structural differences that account for Rlf-RBD's similar affinity for both Ras and Rap (unlike Raf and RalGDS which prefer one or the other).\",\n      \"method\": \"NMR structure determination, chemical shift perturbation mapping\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with functional interface mapping, moderate evidence from single lab with structural and binding data\",\n      \"pmids\": [\"9753431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The human CNK2 scaffold protein interacts with Rlf via CNK2's interaction mapped to the GEF (CDC25 homology) domain of Rlf. CNK2 can simultaneously interact with Raf and Rlf, suggesting it integrates MAPK and Ral signaling pathways. CNK2 is localized to the lateral plasma membrane in MDCK cells.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, subcellular fractionation and immunofluorescence\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal co-IP with domain mapping, single lab, moderate evidence\",\n      \"pmids\": [\"14597674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Rgl2/Rlf GEF accumulates on endosomes where R-Ras activity is high, and R-Ras drives RalA activation specifically on endosomes via Rgl2/Rlf. shRNA-mediated suppression of R-Ras reduced endosomal RalA activity and suppressed calcium-triggered exocytosis in PC12 cells, placing Rlf downstream of R-Ras on endosomes in the regulation of exocytosis.\",\n      \"method\": \"FRET-based activity probes, shRNA knockdown, R-Ras GAP expression, co-localization by fluorescence microscopy, exocytosis assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (FRET probes, shRNA, GAP overexpression, functional exocytosis readout), strong mechanistic chain\",\n      \"pmids\": [\"17344481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The crystal structure of the catalytic module of Rlf (REM + CDC25-homology domains) was determined, revealing an extended three-stranded β-sheet ('flagpole') that stabilizes the orientation of the REM domain relative to the CDC25-homology domain. A proline-rich sequence unique to Rlf within the flagpole was found to interact with SH3 domain-containing proteins, and conformational pre-selection of this site contributes to SH3 domain binding selectivity.\",\n      \"method\": \"X-ray crystallography, SH3 domain pulldown, structural analysis\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional validation of SH3 interaction, single lab but orthogonal structural + biochemical methods\",\n      \"pmids\": [\"23891840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structures of Rlf in complex with Ral (RalA/RalB) were solved in two different crystal forms representing different steps of the nucleotide exchange reaction, providing mechanistic insight into CDC25-HD-catalyzed exchange. Mutagenesis of the binding interface confirmed selectivity determinants for Ral over other Ras-family GTPases. In vitro GEF activity was confirmed with recombinant proteins.\",\n      \"method\": \"X-ray crystallography (two crystal forms), site-directed mutagenesis, in vitro GEF activity assay with recombinant proteins\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures of reaction intermediates + mutagenesis + in vitro enzymatic assay, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"26687416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"The RLF (Rearranged L-Myc Fusion) gene on chromosome 1p32 was found to undergo intrachromosomal rearrangements fusing its first exon/regulatory region to L-myc in SCLC cell lines and a primary SCLC tumor. Pulsed-field gel electrophoresis established physical linkage between normal rlf and L-myc (<800 kb apart). Independent rearrangements producing identical chimeric proteins suggest the fusion drives tumorigenesis.\",\n      \"method\": \"Southern blotting, somatic cell hybrid mapping, pulsed-field gel electrophoresis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — physical mapping and structural characterization of fusion gene, replicated in primary tumor, but functional mechanism of RLF-Lmyc not fully dissected\",\n      \"pmids\": [\"1649386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Full-length cDNA sequencing revealed that RLF (Rearranged L-Myc Fusion) encodes a 1914 amino acid protein containing 16 widely-spaced zinc finger motifs related to the Zn-15 transcription factor, suggesting a role in transcriptional regulation. The zinc finger motifs are not included in the 79 amino acid N-terminal region involved in RLF-L-myc fusions, indicating the fusion deregulates L-myc expression rather than contributing RLF zinc finger function.\",\n      \"method\": \"cDNA cloning and sequencing, domain analysis, Northern blotting\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — structural characterization by sequencing with functional inference, single lab\",\n      \"pmids\": [\"8545128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Expression of a rlf/L-myc minigene (recapitulating the SCLC fusion) in embryonic stem cells inhibited embryoid body formation and differentiation without increasing proliferation rate, demonstrating that the RLF-L-myc fusion protein blocks differentiation. High-copy transgenic embryos failed to develop, indicating embryonic lethality from the fusion.\",\n      \"method\": \"Stable transfection of ES cells with rlf/L-myc minigene, embryoid body formation assay, transgenic mouse embryo analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss/gain-of-function in ES cells with specific differentiation phenotype, single lab\",\n      \"pmids\": [\"7970711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Loss of RLF (Rearranged L-Myc Fusion) in mouse null mutants causes heart defects resembling Left Ventricular Non-Compaction (LVNC). In situ hybridization localized RLF expression to the endocardium, epicardium, and transiently to cardiomyocytes during heart looping. RNA-seq of mutant hearts revealed attenuated JAGGED1 expression and defective NOTCH signaling as molecular correlates, consistent with RLF acting as an epigenetic modifier maintaining DNA methylation patterns required for correct NOTCH pathway gene regulation.\",\n      \"method\": \"ENU mutant mouse lines, histological analysis, in situ hybridization, RNA-seq\",\n      \"journal\": \"Differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two independent mutant lines with histological and transcriptomic phenotyping, but biochemical epigenetic mechanism not directly demonstrated in this paper\",\n      \"pmids\": [\"27930960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CRISPR/Cas9 somatic editing to generate a Rlf-Mycl-driven mouse model demonstrated that the RLF-MYCL gene fusion (found in up to 7% of ASCL1+ SCLC) accelerates murine SCLC transformation, increases proliferation, and enhances metastatic dissemination and site diversity, establishing RLF-MYCL as a functional oncogenic driver fusion in SCLC.\",\n      \"method\": \"CRISPR/Cas9 somatic genome editing in mouse, tumor growth and metastasis analysis, gene expression profiling\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetically engineered mouse model with direct functional readouts of transformation, proliferation and metastasis; validated against human tumor gene expression\",\n      \"pmids\": [\"34344693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"In the Xenopus replication licensing system, RLF-B was shown to be functionally and physically distinct from XCdc6. Active XCdc6 loads onto chromatin in extracts with defective RLF, yet both RLF-M and RLF-B are still required for licensing of XCdc6-containing chromatin. Immunoprecipitation and standard chromatography separated RLF-B from XCdc6, placing RLF-B function after XCdc6 binding in the licensing pathway.\",\n      \"method\": \"Immunodepletion, chromatography fractionation, chromatin-binding assay in Xenopus egg extracts\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical methods establishing epistatic order and physical distinction, replicated in Xenopus system foundational for mammalian licensing\",\n      \"pmids\": [\"10074431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RLF-M (the M component of Xenopus replication licensing factor) was shown to consist of all six MCM/P1 family members (XMcm2–XMcm7) forming ~400 kDa complexes. Neither of two sub-fractions (XMcm3/5 or XMcm2/4/6/7) provided RLF-M activity alone. All six MCM proteins bind synchronously to chromatin before S-phase and are displaced as S-phase proceeds.\",\n      \"method\": \"Glycerol gradient sedimentation, gel filtration, co-immunoprecipitation with anti-XMcm3, chromatin-binding assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical reconstitution and fractionation with activity assays, multiple orthogonal methods, foundational study\",\n      \"pmids\": [\"9214646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RLF-B was purified from Xenopus egg extracts and identified as Cdt1. Geminin binds and inhibits RLF-B/Cdt1, preventing replication origin licensing in metaphase. Immunodepletion of geminin from metaphase extracts restored origin assembly, and CDK inhibition only stimulated origin assembly after geminin depletion, placing geminin-mediated inhibition of RLF-B/Cdt1 as the primary block to origin re-licensing in higher eukaryotes.\",\n      \"method\": \"Protein purification, immunodepletion, mass spectrometry identification, chromatin-binding/licensing assay in Xenopus egg extracts\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — protein purification and identification plus functional epistasis with immunodepletion, replicated in multiple experimental conditions, >390 citations\",\n      \"pmids\": [\"11175741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Endogenous Xenopus geminin escapes proteolysis upon mitotic exit but does not associate with Cdt1/RLF-B during late mitosis and early G1; only after nuclear import does geminin become reactivated to bind Cdt1/RLF-B, establishing the nucleus as the compartment where geminin inhibits relicensing during late interphase.\",\n      \"method\": \"Xenopus egg extract fractionation, co-immunoprecipitation, nuclear import assay, licensing assay\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical methods demonstrating compartment-dependent activation of geminin-Cdt1/RLF-B inhibition, strong mechanistic findings\",\n      \"pmids\": [\"11967157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Tryptophan B27 of RLF (INSL3) was identified as the critical receptor-binding residue through chemical synthesis of RLF analogues with single amino acid replacements. Ala(B27), Leu(B27), and des(B27-31) RLF showed >97% reduction in receptor binding, while aromatic substitutions retained more activity, indicating an aromatic ring system at the β- or γ-position is required. D-Pro substitution at B25 caused structural rearrangement and 96% loss of activity.\",\n      \"method\": \"Chemical peptide synthesis of analogues, receptor-binding competition assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis via chemical synthesis with quantitative receptor binding, multiple analogues tested\",\n      \"pmids\": [\"10074360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Structure-function analysis of RLF/INSL3 binding to LGR8 (RXFP2) identified Trp B27, Arg B16, and Val B19 as the most important binding residues (alanine replacements causing 99.5%, 96%, and 93.9% reductions in receptor affinity respectively). These residues form a contiguous binding area when the C-terminal B chain folds back against the central helix. An extended region of distributed small contributions also drives the picomolar binding affinity.\",\n      \"method\": \"Chemical synthesis of single-amino-acid replacement analogues, receptor binding competition assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic alanine-scan mutagenesis via chemical synthesis with quantitative receptor binding, mechanistic model proposed and supported\",\n      \"pmids\": [\"16844694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The signal initiation structure of RLF/INSL3 was identified using analogue synthesis; signal induction was found to be a function of the peptide bond rather than specific amino acid side chains, with ligand binding to LGR8 forcing certain peptide bonds into a signaling conformation.\",\n      \"method\": \"Chemical synthesis of RLF analogues, cAMP production assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 method — chemical synthesis with functional cAMP readout, but single lab, mechanistic model is somewhat speculative\",\n      \"pmids\": [\"17676766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Replacement of the A11-B10 disulfide bond in RLF/INSL3 by an isopeptide bond abolished cAMP production without affecting receptor binding, separating the receptor-binding and signal activation functions. Replacing A24-B22 disulfide reduced potency proportional to binding, while replacing A10-A15 reduced binding 3-fold but maintained 100% efficacy, identifying distinct functional roles for each disulfide bond.\",\n      \"method\": \"Chemical synthesis of disulfide-to-amide substituted analogues, receptor binding assay, cAMP production assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic chemical synthesis with orthogonal binding and signaling readouts, clear separation of binding and signaling sites\",\n      \"pmids\": [\"22574850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Native boar RLF/INSL3 was purified from testicular Leydig cells and shown to be a monomeric B-C-A domain structure (not the two-chain form predicted). MS/MS at 100% sequence coverage confirmed three site-specific disulfide bonds. The native monomer retained full biological activity at RXFP2-expressing HEK-293 cells, and was found secreted into testicular venous blood.\",\n      \"method\": \"Protein purification, reverse-phase HPLC, MS/MS and peptide mass fingerprinting, RXFP2-cell cAMP bioassay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — native protein purification with full sequence coverage MS and functional validation, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"21899516\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RLF (as the human RalGDS-Like Factor/RALGDS2) functions as a Ras-effector guanine nucleotide exchange factor (GEF) that couples active Ras—via direct GTP-dependent binding through its C-terminal RBD (ubiquitin-fold, NMR structure solved)—to activation of RalA/RalB GTPases through its REM+CDC25-homology catalytic module (crystal structure solved in complex with Ral), driving c-fos transcription and cell proliferation; on endosomes it operates downstream of R-Ras to promote RalA-dependent exocytosis; a scaffold protein CNK2 binds Rlf's GEF domain and may integrate Ral and MAPK signaling; separately, the human RLF zinc-finger protein (Rearranged L-Myc Fusion) acts as a transcriptional/epigenetic regulator whose fusion with MYCL (via intrachromosomal rearrangement at 1p32) drives SCLC oncogenesis and whose loss impairs NOTCH signaling and causes cardiac non-compaction defects in mice.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers.\n\n**Classification:**\n\nThe human gene RLF (Rearranged L-Myc Fusion, also known as RLFL, a zinc finger protein) is the canonical target. However, the corpus contains multiple alias collisions:\n\n- **INSL3/RLF (relaxin-like factor)**: Papers [5],[7],[8],[9],[10],[12],[14],[15],[19],[21],[24],[25] and many curated papers — These describe INSL3/insulin-like factor 3, a different gene whose older alias \"RLF\" (relaxin-like factor) collides with the symbol. EXCLUDE (alias collision).\n- **Xenopus RLF-B/RLF-M (replication licensing factor)**: Papers [1],[3],[6],[17] — These describe replication licensing factor components (Cdt1, MCM complexes). The \"RLF\" here means \"Replication Licensing Factor,\" not the human gene RLF. EXCLUDE (alias collision).\n- **Plant RLF (Arabidopsis/Marchantia)**: Papers [23],[41],[42] — Plant cytochrome b5-like protein. EXCLUDE (symbol collision, fundamentally incompatible organism/function).\n- **RLF-LPI computational method**: Paper [31] — About lncRNA-protein interaction prediction framework. EXCLUDE (unrelated).\n- **RLF cloning method**: Paper [32] — Restriction-ligation-free cloning method. EXCLUDE (unrelated).\n\n**Papers about the canonical human RLF (zinc finger protein, chromosome 1p32, fused to L-MYC in SCLC):**\n- [2],[4],[11],[13],[16],[20],[22],[26],[27],[28],[29],[30],[35],[36],[37],[38],[39],[40] — Need further review.\n\nSpecifically:\n- [2] Rlf as Ras effector/RalGEF — KEEP (canonical RLF protein)\n- [4] RalGDS-like factor Rlf — KEEP\n- [11] CNK2 interacts with Rlf — KEEP\n- [13] Rgl2/Rlf in R-Ras/RalA signaling — KEEP\n- [16] Rlf-Mycl fusion in SCLC — KEEP\n- [20] Intrachromosomal rearrangements fusing L-myc and rlf — KEEP\n- [22] Structure of Rlf Ras-binding domain — KEEP\n- [26] RLF cDNA, zinc finger protein — KEEP\n- [27] Rearrangements/co-amplification — KEEP (structural/genetic, minimal mechanism)\n- [28] Geminin inhibits RLF-B/Cdt1 — EXCLUDE (replication licensing factor alias)\n- [29] Replacement of disulfides in RLF/INSL3 — EXCLUDE (INSL3 alias)\n- [30] Expression of rlf/L-myc minigene — KEEP\n- [35] Loss of RLF in heart development — KEEP\n- [36] Structure of Rlf GEF domain with Ral — KEEP\n- [37] Ras binding domain of Rlf — KEEP\n- [38] Rlf crystal structure, SH3 interactions — KEEP\n- [39] Myocardial infarction, RLF as causal gene — expression/biomarker study, no mechanism. EXCLUDE (expression correlation only)\n- [40] rlf-L-myc chimeric protein in SCLC — KEEP\n\nCurated papers: Most are about INSL3/JAK3/chromosome biology — EXCLUDE. BioPlex papers [2],[3] mention RLF interactions in large interactome screens — these are high-throughput MS, could note but very low confidence. Paper [6] geminin/Cdt1 = replication licensing alias — EXCLUDE.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"RLF (RalGDS-like factor) was identified as a novel protein containing a Cdc25-homology domain (~30% identity with RalGDS) and a C-terminal Ras-binding domain. In vitro binding studies showed the C-terminal 91 amino acid region of Rlf directly associates with GTP-bound Ras and Rap1A (Kd ~0.6 µM and ~0.4 µM, respectively) but not with their GDP-bound forms, defining Rlf as a putative effector for Ras and Rap1A.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro binding assays (pull-down with recombinant proteins), deletion mapping\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding with quantified Kd, yeast two-hybrid, deletion mapping; replicated in subsequent studies\",\n      \"pmids\": [\"8710374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Rlf functions as a guanine nucleotide exchange factor (GEF) for the small GTPase Ral. Co-expression with active Ras mutants showed Rlf associates in vivo with RasV12 and the effector-domain mutant RasV12G37 but not with RasV12E38 or RasV12C40. Active Ras stimulates Rlf-induced Ral activation, and a membrane-targeted constitutively active form (Rlf-CAAX) activates both Ral and the c-fos promoter independently of MEK, inducing NIH 3T3 cell proliferation under low-serum conditions.\",\n      \"method\": \"Co-immunoprecipitation in vivo, Ral activation assay, reporter gene assay (c-fos promoter/SRE), dominant-negative Ras, MEK inhibitor (PD98059), NIH 3T3 proliferation assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (co-IP, GEF activity assay, reporter gene, pharmacological inhibition, cell growth assay) in single study\",\n      \"pmids\": [\"9362489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The Ras-binding domain (RBD) of Rlf adopts a ubiquitin superfold (βαβββαβ topology) structurally similar to RalGDS-RBD, as determined by NMR. Unlike Raf-RBD and RalGDS-RBD (which prefer Ras or Rap respectively), Rlf-RBD binds both Ras and Rap1A with similar affinity. Chemical shift mapping identified the Ras-binding interface and revealed a binding mode similar to the Rap·Raf-RBD complex.\",\n      \"method\": \"NMR spectroscopy (3D structure determination), chemical shift perturbation mapping\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with functional binding interface mapping\",\n      \"pmids\": [\"9753431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The minimal Ras-binding domain of Rlf was mapped to residues 657–778 by N- and C-terminal deletions. Rlf-RBD shows different Ras mutant binding characteristics compared to Raf-1 RBD. Alanine substitution of a conserved lysine (K687) in the predicted binding interface significantly reduced affinity for Ras-GTP, confirming its role in Ras interaction.\",\n      \"method\": \"ELISA-based binding assay with Ras mutants, deletion mutagenesis, alanine substitution mutagenesis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional binding assay; single lab, single study\",\n      \"pmids\": [\"9299525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"The RLF gene on chromosome 1p32 is physically linked to L-MYC (separated by <800 kb), and intrachromosomal rearrangements fuse the first exon of RLF to L-MYC in small-cell lung cancer (SCLC) cell lines with amplified L-MYC, producing a chimeric RLF-L-MYC fusion protein. Independent rearrangements producing identical fusion proteins suggest a selected role for the fusion in SCLC development.\",\n      \"method\": \"Somatic cell hybrid mapping, pulsed-field gel electrophoresis (PFGE), Southern blotting, molecular cloning of fusion gene\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — physical mapping, molecular cloning, multiple independent rearrangements identified; replicated in subsequent studies\",\n      \"pmids\": [\"1649386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The full-length RLF cDNA encodes a 1914 amino acid protein containing sixteen widely spaced zinc finger motifs related to the Zn-15 transcription factor. RLF is widely expressed in fetal and adult tissues. The zinc fingers are not included in the 79 amino acid N-terminal region involved in RLF-L-MYC fusions, and the transforming ability of the RLF-L-MYC fusion is indistinguishable from normal L-MYC, suggesting RLF rearrangements serve to deregulate L-MYC expression.\",\n      \"method\": \"Full-length cDNA cloning and sequencing, Northern blotting, comparison of transforming activity (focus formation assay)\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — full-length cDNA characterization, domain analysis, functional comparison with normal L-MYC; foundational paper\",\n      \"pmids\": [\"8545128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Expression of an rlf/L-myc minigene (recapitulating the SCLC rearrangement under rlf promoter control) in embryonic stem (ES) cells did not increase proliferation rate but severely impaired embryoid body formation and outgrowth/differentiation of cells from embryoid bodies. High-copy transgenic embryos failed to develop, suggesting the RLF-L-MYC fusion protein blocks early differentiation.\",\n      \"method\": \"Stable transfection of ES cells, embryoid body assay, transgenic mouse generation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function/gain-of-function with defined cellular phenotype (differentiation block); single lab\",\n      \"pmids\": [\"7970711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The human CNK2A protein (homologue of Drosophila CNK) interacts with Rlf through the GEF (CDC25-homology) domain of Rlf. CNK2 also interacts with Raf, suggesting it may integrate signals between MAPK and Ral pathways. CNK2 is found in membrane and cytoplasmic fractions, with full-length CNK2 localizing to the lateral plasma membrane in MDCK cells.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping (deletion constructs), subcellular fractionation, immunofluorescence localization\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP with domain mapping; interaction confirmed with Rlf GEF domain but not deeply validated\",\n      \"pmids\": [\"14597674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Rgl2/Rlf (the RalGDS family GEF) accumulates on early and recycling endosomes where R-Ras activity is high. R-Ras recruits Rgl2/Rlf to endosomes, resulting in high local RalA activity. shRNA-mediated suppression of R-Ras reduced endosomal RalA activity and suppressed calcium-triggered exocytosis in PC12 cells, placing Rgl2/Rlf downstream of R-Ras on endosomes and upstream of RalA in the exocytosis pathway.\",\n      \"method\": \"FRET-based activity probes for R-Ras and RalA, shRNA knockdown, R-Ras GAP overexpression, exocytosis assay (PC12 cells), immunofluorescence/subcellular fractionation\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (FRET probes, shRNA, dominant-negative, functional exocytosis assay) demonstrating pathway position\",\n      \"pmids\": [\"17344481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The crystal structure of the catalytic module of Rlf (REM + CDC25-homology domains) was determined. The structure features an extended three-stranded β-sheet called the 'flagpole,' a conserved element in the RalGDS family that stabilizes the REM domain orientation relative to the CDC25-HD. A proline-rich sequence in the flagpole is unique to Rlf and mediates interactions with SH3 domain-containing proteins via conformational pre-selection, contributing to SH3 domain selectivity.\",\n      \"method\": \"X-ray crystallography, identification of SH3 domain interactors, binding affinity measurements\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional validation of SH3 domain interactions and conformational pre-selection mechanism\",\n      \"pmids\": [\"23891840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The crystal structure of Rlf in complex with the small G-protein Ral was determined in two different crystal forms representing different conformational intermediates of the nucleotide exchange reaction. The structure elucidated the catalytic mechanism of CDC25-HD-mediated nucleotide exchange and identified selectivity determinants at the Rlf·Ral binding interface. Mutagenesis of selectivity determinants confirmed the basis for Rlf's specificity for RalA and RalB over other Ras-family GTPases.\",\n      \"method\": \"X-ray crystallography (two crystal forms), recombinant protein exchange activity assays, site-directed mutagenesis of selectivity determinants\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mechanistic insight into exchange reaction intermediates, confirmed by mutagenesis and in vitro activity assays\",\n      \"pmids\": [\"26687416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Loss of RLF (Rearranged L-Myc Fusion zinc finger protein) in Rlf null mutant mice (generated by ENU mutagenesis) causes heart defects resembling Left Ventricular Non-Compaction (LVNC) at high penetrance (E11.5–E14.5). RLF is expressed in endocardium, epicardium, and transiently in cardiomyocytes. RNA-seq of Rlf mutant hearts revealed attenuated JAGGED1 expression and defective NOTCH pathway signaling as likely contributors, consistent with RLF acting as an epigenetic modifier that maintains correct gene regulatory networks during heart development.\",\n      \"method\": \"ENU mutagenesis (two independent alleles), timed mating histological analysis, in situ hybridization, RNA-seq of mutant hearts\",\n      \"journal\": \"Differentiation; research in biological diversity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two independent ENU alleles with consistent cardiac phenotype and transcriptomic pathway analysis; mechanism (epigenetic modifier affecting NOTCH) inferred but not biochemically reconstituted\",\n      \"pmids\": [\"27930960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The in-frame RLF-MYCL gene fusion drives oncogenesis in small-cell lung cancer (SCLC). Using CRISPR/Cas9 somatic editing to generate a Rlf-Mycl mouse model, the fusion was shown to accelerate SCLC transformation and proliferation, and to increase metastatic dissemination and diversity of metastatic sites. Gene expression profiles of mouse Rlf-Mycl tumors resembled human RLF-MYCL SCLC, establishing RLF-MYCL as the first demonstrated fusion oncogenic driver in SCLC.\",\n      \"method\": \"CRISPR/Cas9 somatic genome editing (knock-in mouse model), tumor growth and metastasis quantification, RNA-seq gene expression profiling, comparison to human SCLC datasets\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetically engineered mouse model with CRISPR, quantitative phenotyping of proliferation and metastasis, transcriptomic validation against human data\",\n      \"pmids\": [\"34344693\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RLF (Rearranged L-Myc Fusion) encodes a large zinc finger protein (1914 aa, Zn-15-related) that functions as a Ras effector and selective GEF for RalA/RalB: it binds GTP-Ras via a C-terminal ubiquitin-fold RBD (structure solved by NMR), activates Ral through its CDC25-homology domain (structure solved by X-ray crystallography in complex with Ral, revealing exchange reaction intermediates), and integrates R-Ras signaling on endosomes to promote RalA-dependent exocytosis; its proline-rich flagpole region mediates SH3 domain interactions; in development it is required for normal cardiac chamber formation via NOTCH/JAGGED1 signaling; and its chromosomal fusion to MYCL (L-MYC) at 1p32, originally identified in SCLC, is a bona fide oncogenic driver that accelerates tumor proliferation and metastasis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"The gene symbol RLF maps to at least three distinct biological entities in the literature: (1) RLF/Rgl2, a Ras-effector guanine nucleotide exchange factor (GEF) that activates RalA/RalB GTPases through its REM and CDC25-homology catalytic module upon recruitment by GTP-bound Ras or R-Ras via a C-terminal ubiquitin-fold Ras-binding domain, thereby driving c-fos transcription, cell proliferation, and endosomal exocytosis [PMID:9362489, PMID:17344481, PMID:26687416]; (2) the RLF zinc-finger protein (Rearranged L-Myc Fusion), a 1914-amino-acid transcriptional/epigenetic regulator whose intrachromosomal rearrangement at 1p32 generates an RLF-MYCL fusion that drives small-cell lung cancer transformation and metastasis, while its loss in mice causes left ventricular non-compaction through attenuated NOTCH signaling [PMID:1649386, PMID:34344693, PMID:27930960]; and (3) RLF/INSL3, a peptide hormone secreted by testicular Leydig cells as a monomeric B-C-A chain that binds RXFP2 (LGR8) with picomolar affinity through critical residues including Trp B27, Arg B16, and Val B19, with distinct disulfide bonds mediating receptor binding versus cAMP signal activation [PMID:16844694, PMID:22574850, PMID:21899516]. In the Xenopus replication licensing field, \\\"RLF\\\" historically denoted a two-component licensing activity: RLF-M corresponds to the MCM2–7 hexamer, and RLF-B was identified as Cdt1, whose inhibition by geminin prevents origin re-licensing after S-phase entry [PMID:9214646, PMID:11175741].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"The discovery that intrachromosomal rearrangements at 1p32 fuse RLF regulatory sequences to L-myc in SCLC established RLF as a locus involved in oncogenic gene fusions, raising the question of what RLF itself encodes and how the fusion drives tumorigenesis.\",\n      \"evidence\": \"Southern blotting and pulsed-field gel electrophoresis in SCLC cell lines and a primary tumor\",\n      \"pmids\": [\"1649386\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RLF protein function unknown at this stage\", \"mechanism by which fusion drives transformation not tested\", \"only structural characterization of genomic rearrangement\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Demonstrating that an rlf/L-myc minigene blocks ES cell differentiation without increasing proliferation showed the fusion acts as a differentiation inhibitor, separating its oncogenic mechanism from simple mitogenic drive.\",\n      \"evidence\": \"Stable transfection of ES cells with rlf/L-myc minigene, embryoid body formation assay, transgenic mouse lethality\",\n      \"pmids\": [\"7970711\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream targets of the fusion not identified\", \"relevance to human SCLC in vivo not tested\", \"RLF protein function still unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Full-length cDNA sequencing revealed RLF encodes a large zinc-finger protein (1914 aa, 16 Zn-finger motifs), suggesting transcriptional regulatory function and showing the fusion removes the zinc-finger domains, implying it deregulates L-myc rather than contributing RLF domains.\",\n      \"evidence\": \"cDNA cloning, sequencing, domain analysis, Northern blotting\",\n      \"pmids\": [\"8545128\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct evidence of transcriptional activity\", \"zinc-finger targets unknown\", \"expression pattern incompletely characterized\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of Rlf/Rgl2 as a GTP-dependent interactor of Ras and Rap1A with sub-micromolar affinity established a second gene product sharing the RLF name as a candidate Ras effector, opening the question of its downstream signaling target.\",\n      \"evidence\": \"Yeast two-hybrid and in vitro binding with Kd measurements\",\n      \"pmids\": [\"8710374\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream GTPase substrate not yet identified\", \"cellular function unknown\", \"relationship to other RalGDS family members unclear\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showing that Rlf/Rgl2 functions as a Ral GEF activated by Ras, driving c-fos transcription and proliferation, placed Rlf within the Ras→Ral signaling axis and answered what its catalytic activity is. Concurrently, mapping the minimal RBD and identifying the MCM2-7 hexamer as RLF-M in Xenopus licensing advanced understanding of both the GEF and the replication licensing factor.\",\n      \"evidence\": \"GEF assays, co-IP, c-fos reporter, proliferation assays (Rlf/Rgl2); glycerol gradient/gel filtration/chromatin binding (RLF-M/MCM)\",\n      \"pmids\": [\"9362489\", \"9299525\", \"9214646\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Ral selectivity not yet solved\", \"in vivo Ras–Rlf pathway context not defined\", \"RLF-B identity still unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Solving the NMR structure of the Rlf-RBD revealed a ubiquitin superfold and mapped the Ras-binding interface, explaining why Rlf binds both Ras and Rap with similar affinity unlike Raf or RalGDS.\",\n      \"evidence\": \"NMR structure determination and chemical shift perturbation mapping\",\n      \"pmids\": [\"9753431\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length structure unknown\", \"no structure of Rlf-RBD in complex with Ras\", \"catalytic domain structure not yet solved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Biochemical separation of RLF-B from Cdc6 in Xenopus extracts established that RLF-B acts after Cdc6 loading in origin licensing, defining the epistatic order. Simultaneously, structure-activity studies on RLF/INSL3 identified Trp B27 as the critical receptor-binding residue.\",\n      \"evidence\": \"Immunodepletion and chromatography in Xenopus extracts (RLF-B); chemical synthesis of INSL3 analogues with receptor binding assays\",\n      \"pmids\": [\"10074431\", \"10074360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of RLF-B still unknown\", \"INSL3 signaling mechanism not dissected\", \"structural basis of INSL3–receptor interaction not solved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Purification and identification of RLF-B as Cdt1, inhibited by geminin, resolved a long-standing question in the licensing field and established geminin as the primary block to origin re-licensing in metazoans.\",\n      \"evidence\": \"Protein purification, mass spectrometry, immunodepletion, and licensing assays in Xenopus egg extracts\",\n      \"pmids\": [\"11175741\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of Cdt1/RLF-B by ubiquitin-dependent degradation not yet described\", \"human system validation needed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showing that geminin reactivation to bind Cdt1/RLF-B requires nuclear import resolved how licensing inhibition is compartmentalized, explaining the temporal window for licensing in G1.\",\n      \"evidence\": \"Co-immunoprecipitation and nuclear import assay in Xenopus egg extracts\",\n      \"pmids\": [\"11967157\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of geminin reactivation not molecularly defined\", \"applicability to somatic cell cycles not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The finding that scaffold protein CNK2 binds the Rlf GEF domain while simultaneously interacting with Raf suggested integration of Ral and MAPK pathways at the plasma membrane.\",\n      \"evidence\": \"Co-immunoprecipitation and domain mapping in MDCK cells\",\n      \"pmids\": [\"14597674\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of CNK2–Rlf interaction on Ral activation not measured\", \"single lab, no reciprocal knockdown\", \"in vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Systematic alanine scanning of INSL3 identified a contiguous binding surface (Trp B27, Arg B16, Val B19) on the B-chain responsible for picomolar-affinity binding to RXFP2, providing a structural pharmacophore.\",\n      \"evidence\": \"Chemical synthesis of single-amino-acid replacement analogues with quantitative receptor binding competition\",\n      \"pmids\": [\"16844694\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal structure of INSL3–RXFP2\", \"signaling activation mechanism not separated from binding\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that Rlf/Rgl2 accumulates on endosomes downstream of R-Ras to activate RalA and promote exocytosis established a compartment-specific signaling role distinct from plasma membrane Ras signaling.\",\n      \"evidence\": \"FRET-based activity probes, shRNA knockdown, exocytosis assay in PC12 cells\",\n      \"pmids\": [\"17344481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cargo specificity of Rlf-dependent exocytosis unknown\", \"whether R-Ras–Rlf axis operates in non-neuronal cells not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Purification of native boar INSL3/RLF revealed a single-chain B-C-A monomer (not two-chain) with full RXFP2 activity, revising the understanding of its mature bioactive form. Disulfide-to-amide substitution studies separated binding from signaling, showing the A11-B10 disulfide is essential for cAMP activation but dispensable for binding.\",\n      \"evidence\": \"Native protein purification with MS/MS, chemical synthesis of disulfide analogues, cAMP and binding assays\",\n      \"pmids\": [\"21899516\", \"22574850\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Three-dimensional structure of native single-chain INSL3 not solved\", \"mechanism of conformational signaling activation at receptor not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The crystal structure of the Rlf catalytic module revealed a flagpole β-sheet stabilizing REM–CDC25 orientation and a proline-rich sequence mediating SH3 domain interactions, providing the first structural view of the catalytic core.\",\n      \"evidence\": \"X-ray crystallography and SH3 domain pulldown\",\n      \"pmids\": [\"23891840\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of physiological SH3-containing partners not established\", \"full-length Rlf structure including RBD not available\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structures of Rlf in complex with RalA and RalB captured two intermediates of the nucleotide exchange reaction, providing the first structural snapshots of CDC25-HD-catalyzed Ral activation and explaining substrate selectivity.\",\n      \"evidence\": \"X-ray crystallography in two crystal forms, mutagenesis, in vitro GEF assay\",\n      \"pmids\": [\"26687416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Ras binding at the RBD allosterically activates the GEF domain not structurally resolved\", \"kinetic parameters of full-length Rlf GEF activity not reported\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Mouse knockout of the zinc-finger RLF gene revealed left ventricular non-compaction linked to attenuated JAGGED1/NOTCH signaling, establishing RLF as an epigenetic regulator required for cardiac development.\",\n      \"evidence\": \"ENU mutant mouse lines, histology, in situ hybridization, RNA-seq\",\n      \"pmids\": [\"27930960\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct DNA-binding targets of RLF zinc fingers not identified\", \"epigenetic mechanism (DNA methylation regulation) inferred but not biochemically demonstrated\", \"human cardiac disease association not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CRISPR-engineered RLF-MYCL fusions in mouse lung confirmed the fusion as a functional oncogenic driver that accelerates SCLC and enhances metastasis, closing a 30-year question about whether the fusion is causative rather than correlative.\",\n      \"evidence\": \"CRISPR/Cas9 somatic editing in mouse, tumor growth and metastasis analysis, gene expression profiling\",\n      \"pmids\": [\"34344693\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Therapeutic vulnerabilities of RLF-MYCL-driven SCLC not defined\", \"whether wild-type RLF has tumor-suppressive function not tested\", \"downstream transcriptional targets of the fusion not comprehensively validated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include: (i) the direct transcriptional targets of the RLF zinc-finger protein and how it regulates DNA methylation; (ii) the structural basis for allosteric coupling between Ras binding at the RBD and GEF activation of Ral in full-length Rlf/Rgl2; and (iii) the three-dimensional structure of the INSL3–RXFP2 signaling complex.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length structure of Rlf/Rgl2 with both RBD and GEF domains\", \"RLF zinc-finger DNA binding specificity completely uncharacterized\", \"INSL3–RXFP2 co-crystal or cryo-EM structure not available\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 5, 7]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [9, 11]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [17, 18, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [11, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [13, 14, 15]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 12]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"complexes\": [\n      \"MCM2-7 (as RLF-M in Xenopus licensing)\"\n    ],\n    \"partners\": [\n      \"HRAS\",\n      \"RRAS\",\n      \"RAP1A\",\n      \"RALA\",\n      \"RALB\",\n      \"CNK2\",\n      \"GMNN\",\n      \"RXFP2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"RLF is a large zinc finger protein that functions as a Ras-regulated guanine nucleotide exchange factor (GEF) for RalA and RalB, coupling Ras and R-Ras signaling to Ral-dependent cellular processes including exocytosis, proliferation, and transcriptional activation. Its C-terminal Ras-binding domain adopts a ubiquitin superfold that recognizes GTP-loaded Ras and Rap1A [PMID:8710374, PMID:9753431], while its central CDC25-homology domain catalyzes nucleotide exchange on Ral with selectivity determined by specific interface residues resolved crystallographically [PMID:26687416, PMID:23891840]. R-Ras recruits RLF to endosomes where it locally activates RalA to promote calcium-triggered exocytosis [PMID:17344481], and loss of RLF in mice causes cardiac defects resembling left ventricular non-compaction through attenuated JAGGED1/NOTCH signaling [PMID:27930960]. The RLF locus on chromosome 1p32 undergoes intrachromosomal rearrangement with MYCL in small-cell lung cancer, producing a fusion oncoprotein that accelerates tumor proliferation and metastasis [PMID:1649386, PMID:34344693].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Identification of RLF as a gene physically linked to L-MYC on chromosome 1p32, fused to L-MYC in SCLC, established it as a locus of recurrent somatic rearrangement in lung cancer.\",\n      \"evidence\": \"Somatic cell hybrid mapping, PFGE, Southern blotting, and molecular cloning of chimeric fusion gene in SCLC cell lines\",\n      \"pmids\": [\"1649386\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the fusion drives oncogenesis or merely deregulates L-MYC expression was unresolved\", \"Full-length RLF protein function unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Cloning of full-length RLF cDNA revealed a 1914 amino acid protein with sixteen Zn-15-related zinc fingers, broadly expressed in fetal and adult tissues, and showed that the RLF-LMYC fusion's transforming ability was indistinguishable from L-MYC alone, suggesting deregulated expression rather than a neomorphic protein.\",\n      \"evidence\": \"Full-length cDNA sequencing, Northern blotting, focus formation assay comparing fusion versus wild-type L-MYC\",\n      \"pmids\": [\"8545128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical function of the zinc finger domains uncharacterized\", \"No pathway context for RLF protein\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Discovery that RLF contains a CDC25-homology domain and a C-terminal Ras-binding domain that selectively associates with GTP-bound Ras and Rap1A placed it within the RalGDS family of Ras effectors.\",\n      \"evidence\": \"Yeast two-hybrid screen, in vitro pull-down assays with recombinant proteins, Kd measurements\",\n      \"pmids\": [\"8710374\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GEF activity toward Ral was inferred but not directly demonstrated\", \"Physiological role of dual Ras/Rap binding unclear\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstration that RLF functions as a bona fide GEF for Ral downstream of active Ras, stimulating c-fos promoter activity and serum-independent proliferation via a MEK-independent pathway, established the Ras→RLF→Ral signaling axis.\",\n      \"evidence\": \"Co-IP with Ras effector-domain mutants, Ral activation assays, c-fos/SRE reporter, PD98059 MEK inhibition, NIH 3T3 growth assays\",\n      \"pmids\": [\"9362489\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors of Ral in this context not identified\", \"Contribution relative to RalGDS and Rgl1 not defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"NMR structure of the RLF Ras-binding domain revealed a ubiquitin superfold and mapped the Ras-binding interface, explaining its dual specificity for Ras and Rap1A—unlike Raf-RBD or RalGDS-RBD which show preferential binding.\",\n      \"evidence\": \"NMR spectroscopy (3D structure), chemical shift perturbation mapping; mutagenesis of K687 confirmed interface residue\",\n      \"pmids\": [\"9753431\", \"9299525\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length structural information\", \"How dual Ras/Rap specificity is exploited physiologically unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of CNK2A as a binding partner of the RLF GEF domain suggested a scaffold-mediated integration point between MAPK and Ral signaling pathways.\",\n      \"evidence\": \"Co-immunoprecipitation and deletion mapping in mammalian cells\",\n      \"pmids\": [\"14597674\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interaction based on single Co-IP without reciprocal validation\", \"Functional consequence of CNK2-RLF interaction not demonstrated\", \"No in vivo confirmation\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Localization of RLF to early and recycling endosomes via R-Ras recruitment, where it drives local RalA activation to promote calcium-triggered exocytosis, defined a spatially organized R-Ras→RLF→RalA signaling module on endomembranes.\",\n      \"evidence\": \"FRET-based activity probes for R-Ras and RalA, shRNA knockdown, R-Ras GAP overexpression, PC12 exocytosis assay\",\n      \"pmids\": [\"17344481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endosomal localization applies to all cell types unknown\", \"Cargo specificity of RLF-dependent exocytosis not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Crystal structure of the RLF catalytic module (REM + CDC25-HD) revealed an extended 'flagpole' β-sheet that stabilizes domain orientation, with a unique proline-rich sequence mediating selective SH3 domain interactions through conformational pre-selection.\",\n      \"evidence\": \"X-ray crystallography, SH3 domain binding assays, affinity measurements\",\n      \"pmids\": [\"23891840\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity and biological relevance of SH3-containing partners in vivo not established\", \"Flagpole function in signaling output not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structures of RLF in complex with Ral captured two conformational intermediates of nucleotide exchange, elucidating the catalytic mechanism and the molecular basis of RLF's selectivity for RalA/RalB over other Ras-family GTPases.\",\n      \"evidence\": \"X-ray crystallography (two crystal forms), mutagenesis of selectivity determinants, in vitro exchange assays\",\n      \"pmids\": [\"26687416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How catalytic rate is modulated by upstream Ras binding in the full-length protein is unknown\", \"No structure of a ternary Ras–RLF–Ral complex\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Loss-of-function analysis in mice revealed that RLF is required for normal cardiac chamber formation; Rlf-null embryos develop left ventricular non-compaction-like defects associated with attenuated JAGGED1 expression and defective NOTCH signaling, implicating RLF as an epigenetic or transcriptional regulator in heart development.\",\n      \"evidence\": \"ENU mutagenesis generating two independent Rlf-null alleles, histological analysis, in situ hybridization, RNA-seq of mutant hearts\",\n      \"pmids\": [\"27930960\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the cardiac phenotype is mediated by RLF's GEF activity, zinc finger transcriptional function, or both is unknown\", \"Direct biochemical link between RLF and JAGGED1 regulation not established\", \"No human genetic disease association reported\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CRISPR/Cas9-engineered Rlf-Mycl fusion in a mouse model demonstrated that RLF-MYCL is a bona fide oncogenic driver in SCLC—not merely deregulated L-MYC expression—accelerating proliferation, increasing metastasis, and recapitulating human RLF-MYCL tumor transcriptomes.\",\n      \"evidence\": \"CRISPR/Cas9 somatic knock-in mouse model, quantitative proliferation and metastasis analysis, RNA-seq profiling matched to human SCLC datasets\",\n      \"pmids\": [\"34344693\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which domains of the RLF portion contribute to neomorphic oncogenic activity not determined\", \"Therapeutic vulnerability of RLF-MYCL tumors not explored\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include whether RLF's zinc finger domains confer independent transcription-regulatory activity, how GEF and zinc finger functions are coordinated in vivo, whether the cardiac developmental role is GEF-dependent, and what therapeutic targets the RLF-MYCL fusion exposes in SCLC.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No biochemical characterization of zinc finger domains' DNA/chromatin binding\", \"No structure of full-length RLF or ternary Ras–RLF–Ral complex\", \"Whether RLF mutations cause human cardiac disease is untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 8, 10]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RALA\", \"RALB\", \"KRAS\", \"RRAS\", \"RAP1A\", \"CNKSR2\", \"MYCL\"],\n    \"other_free_text\": []\n  }\n}\n```"}